Effect of glycemic gap on prognosis and complications in vulnerable period of acute heart failure

Glycemic Gap's Impact on Acute Heart Failure Prognosis

  • Lin Zheng Department of Cardiology, Ningbo Fourth Hospital
  • Weifeng Zheng
  • Mingming Zhang
  • Bo Li
DOI: https://doi.org/10.5937/jomb0-52619
Keywords: Glycemic gap, acute heart failure, vulnerable period of heart failure, prognosis, complication

Abstract


Background: To investigate the effect of glycemic gap on the prognosis and complications of heart failure in patients with acute heart failure.

Methods: 100 patients with acute heart failure treated in our hospital from January 2022 to August 2023 were divided into two groups according to the prognosis: good prognosis group (n = 58) and poor prognosis group (n = 42). Univariate analysis of the prognostic factors of acute heart failure patients in vulnerable period, multivariate Logistics regression analysis of the prognostic factors of acute heart failure patients. ROC analysis of the value of glycemic gap in predicting the prognosis of patients with acute heart failure in the vulnerable period of heart failure, and compare the occurrence of complications between the two groups. Including: arrhythmia, angina pectoris, cardiogenic shock, thrombosis.

Results: There was no significant difference in age, sex, history of hypertension, BMI, TG, history of diabetes and serum potassium between the two groups. The glycemic gap, BNP, Ang II, cTnI and SCR in the good prognosis group were lower than those in the poor prognosis group, while LVEF and hemoglobin were higher than those in the poor prognosis group. Binary Logistics regression analysis showed that. Glycemic gap, BNP, Ang II, cTnI, SCR, LVEF and hemoglobin were independent prognostic factors in patients with acute heart failure. The area under the glycemic gap value curve was determined to be 0.8071. The sensitivity of the assessment was 72.8, while the specificity was 70.5, . The incidence of complications in the good prognosis group (1.72%) was significantly lower than that in the poor prognosis group (16.67%).

Conclusions: Glycemic gap is related to the prognosis and complications of heart failure in patients with acute heart failure. Hyperglycemia gap will affect the prognosis of heart failure in patients with acute heart failure, resulting in poor prognosis and increasing the incidence of complications.

References

1. Joung HN, Kwon HS, Baek KH, Song KH, Kim MK. Consistency of the Glycation Gap with the Hemoglobin Glycation Index Derived from a Continuous Glucose Monitoring System. Endocrinol Metab 2020; 35(2): 377-83.
2. Rogers C, Bush N. Heart Failure: Pathophysiology, Diagnosis, Medical Treatment Guidelines, and Nursing Management. Nurs Clin N Am 2015; 50(4): 787-99.
3. Hsing SC, Lin C, Chen JT, Chen YH, Fang WH. Glycemic Gap as a Useful Surrogate Marker for Glucose Variability and Progression of Diabetic Retinopathy. J Pers Med 2021; 11(8): 799.
4. Zarean E, Lattanzi S, Looha MA, Napoli MD, Chou SH, Jafarli A, et al. Glycemic Gap Predicts in-Hospital Mortality in Diabetic Patients with Intracerebral Hemorrhage. J Stroke Cerebrovasc 2021; 30(5): 105669.
5. Zhao J, Xie W, Ye S, Zhang S, Shi W, Cui M, et al. The clinical value of the Controlling Nutritional Status score for predicting prognosis in systolic heart failure cases in the vulnerable phase. Front Nutr 2023; 10: 1084107.
6. Masip J, Povar-Echeverria M, Peacock WF, Jacob J, Gil V, Herrero P, et al. Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients. Intern Emerg Med 2022; 17(5): 1503-16.
7. Wen XS, Luo R, Liu J, Duan Q, Qin S, Xiao J, et al. Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study. Bmc Cardiovasc Disor 2022; 22(1): 193.
8. Zippel-Schultz B, Silber S, Helms TM. [Do telemonitoring centers improve the prognosis of patients with congestive heart failure?]. MMW Fortschr Med 2023; 165(5): 50-3.
9. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42(36): 3599-726.
10. Chunawala ZS, Qamar A, Arora S, Pandey A, Fudim M, Vaduganathan M, et al. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study. J Card Fail 2022; 28(8): 1267-77.
11. Huang S, Wei Q, Zhi X, Wang J, Zhang Z. [Application value of serum sST2 in diagnosis and prognosis of heart failure]. Sheng Wu Gong Cheng Xue Bao 2020; 36(9): 1713-22.
12. Abdin A, Anker SD, Butler J, Coats A, Kindermann I, Lainscak M, et al. 'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor. Esc Heart Fail 2021; 8(6): 4444-53.
13. Savarese G, Stolfo D, Sinagra G, Lund LH. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol 2022; 19(2): 100-16.
14. Li M, Yi T, Fan F, Qiu L, Wang Z, Weng H, et al. Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol 2022; 21(1): 139.
15. Chishiki T, Nagatomo Y, Saji M, Takei M, Goda A, Kohno T, et al. Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice. Int J Cardiol 2022; 365: 91-9.
16. Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Sorensen J, et al. Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study. J Nucl Cardiol 2019; 26(2): 585-97.
17. Kobayashi A, Fujihara K, Yamada MH, Sato T, Yaguchi Y, Kitazawa M, et al. Combined effects of blood pressure and glycemic status on risk of heart failure: a population-based study. J Hypertens 2023; 41(3): 470-5.
18. Zhou Y, Wang C, Che H, Cheng L, Zhu D, Rao C, et al. Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China. Cardiovasc Diabetol 2023; 22(1): 171.
19. Palmiero G, Cesaro A, Vetrano E, Pafundi PC, Galiero R, Caturano A, et al. Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. Int J Mol Sci 2021; 22(11): 5863.
Published
2024/10/13
Issue
Ahead of print
Section
Original paper

Copyright (c) 2024 Lin Zheng, Weifeng Zheng, Mingming Zhang, Bo Li

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.